Delivery Order SPE2DB22D2206-SPE2DB26FDV02
- Not listed
- The Defense Logistics Agency (DLA) awarded a $10,662.57 delivery order to AmerisourceBergen Drug Corp for Tagrisso 80 mg tablets (30-count supply) under a firm fixed-price contract. The award was issued on September 15, 2025, with an ultimate completion date of October 6, 2025. This non-set-aside delivery order will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania, and represents a routine pharmaceutical procurement to support federal medical supply needs....
- The Defense Logistics Agency has awarded a delivery order valued at $11,236.71 to AmerisourceBergen Drug Corp for the supply of Tagrisso 80 mg tablets (30-count packages). This firm fixed-price delivery order, issued on October 29, 2025, with an ultimate completion date of November 20, 2025, represents a non-competitive, non-set-aside award to the pharmaceutical distributor. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $31,987.71 to AmerisourceBergen Drug Corp for the supply of Tagrisso 80 mg tablets (30-count units) on August 27, 2025, with an ultimate completion date of September 18, 2025. This competitive award, with no set-aside designation, reflects firm fixed-price pricing terms and represents a pharmaceutical supply delivery to support federal medical procurement needs. The place of performance is AmerisourceBergen's corporate office...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $10,662.57 on September 16, 2025, for the supply of Tagrisso 80 mg tablets (30-count units). This competitively awarded, firm fixed-price delivery order is scheduled for completion by October 7, 2025, with performance taking place at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting open competition among qualified vendors. This...
- The Defense Logistics Agency awarded a delivery order valued at $10,662.57 to AmerisourceBergen Drug Corp for the supply of Tagrisso 80 mg tablets (30-count packages). This competitive award, issued on August 12, 2025, with an ultimate completion date of September 3, 2025, represents a firm fixed-price delivery order with no set-aside designation. Performance of this contract will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Tagrisso is a...
- The Defense Logistics Agency awarded a delivery order valued at $53,312.85 to AmerisourceBergen Drug Corp for the supply of Tagrisso 80 mg tablets (30-count units). This firm fixed-price delivery order, issued on September 9, 2025, represents a competitively awarded contract with no set-aside designation and an ultimate completion date of September 30, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a $31,987.71 delivery order to AmerisourceBergen Drug Corp for 30-tablet units of Tagrisso 80 mg tablets under a firm fixed price contract. This delivery order, issued on September 25, 2025, with an ultimate completion date of October 17, 2025, represents a non-competitive set-aside award to the pharmaceutical distributor. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded a delivery order valued at $21,325.14 to AmerisourceBergen Drug Corp for the supply of Tagrisso 80 mg tablets (30-count units) on August 25, 2025, with completion scheduled for September 16, 2025. This competitive award, issued under firm fixed pricing with no set-aside designation, supports federal medical procurement needs through AmerisourceBergen's extensive pharmaceutical distribution network. The contractor will perform this delivery order from its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 31, 2025, for the supply of Tagrisso 80 mg tablets (30-count units) with a ceiling value of $11,236.71. This firm fixed-price delivery order represents a competitive, non-set-aside award and is scheduled for completion by November 24, 2025. The order will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania, supporting the federal government's pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $10,662.57 to AmerisourceBergen Drug Corp for the supply of Tagrisso 80 mg tablets (30-count packages) under a firm fixed price contract type. This award, issued on August 12, 2025, with an ultimate completion date of September 3, 2025, represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this delivery order at its corporate office location. The...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB26FDV02Delivery Order
The Defense Logistics Agency awarded a $82.4K delivery order to AmerisourceBergen Drug Corp for the supply of Tagrisso 80 mg tablets (30-count units) under a firm fixed-price contract. The award was made on October 29, 2025, with an ultimate completion date of November 20, 2025. This is a non-set-aside, competitively awarded delivery order that will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement supporting federal medical supply requirements. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at $999.9M through December 2026. AmerisourceBergen, as a major pharmaceutical distributor and critical vendor for federal medical procurement, maintains an extensive portfolio of medical product deliveries across multiple therapeutic domains. The DLA Troop Support Medical contract enables the company to supply brand-name and generic medications, vaccines, and specialized medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard among other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $82.4k | 10/29/25 |